Outlook Therapeutics Inc
F:41ON
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Outlook Therapeutics Inc
F:41ON
|
US |
|
D
|
Dermapharm Holding SE
DUS:DMP
|
DE |
Wall St Price Targets
41ON Price Targets Summary
Outlook Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for 41ON is 11.855 EUR with a low forecast of 3.756 EUR and a high forecast of 24.408 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 41ON's stock price target?
Price Target
11.855
EUR
According to Wall Street analysts, the average 1-year price target for 41ON is 11.855 EUR with a low forecast of 3.756 EUR and a high forecast of 24.408 EUR.
What is the Revenue forecast for Outlook Therapeutics Inc?
Projected CAGR
55%
Over the last 10 years, the compound annual growth rate for Revenue has been -12%. The projected CAGR for the next 8 years is 55%.
What is the Gross Profit forecast for Outlook Therapeutics Inc?
Projected CAGR
871%
The compound annual growth rate for Gross Profit over the next 3 years is 871%.
